Onderneming TriSalus Life Sciences, Inc.
Aandelen
TLSI
US89680M1018
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
9,39 USD | -7,49% | -4,48% | +11,12% |
15/05 | TriSalus Life Sciences, Inc. rapporteert resultaten voor het eerste kwartaal dat eindigde op 31 maart 2024 | CI |
15/05 | TriSalus Life Sciences, Inc. Geeft verkoopprognose voor het hele jaar 2024 | CI |
Vakgebied
Aantal werknemers: 112
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Innovative Drug Delivery Technology and Immune-oncology Therapeutics
100,0
%
| - | - | 19 | 100,0 % | - |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | nan % | 19 | 100,0 % | - |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Mary Szela
CEO | Chief Executive Officer | 60 | 01-01-18 |
Sean Murphy
DFI | Director of Finance/CFO | 71 | 10-08-23 |
Steven Katz
CTO | Chief Tech/Sci/R&D Officer | 49 | 10-08-23 |
Bryan Cox
CTO | Chief Tech/Sci/R&D Officer | 62 | 10-08-23 |
Jennifer Stevens
LAW | General Counsel | 63 | 10-08-23 |
Richard Marshak
PRN | Corporate Officer/Principal | 65 | 10-08-23 |
Jodi Devlin
PRN | Corporate Officer/Principal | - | 05-09-23 |
James Alecxih
PRN | Corporate Officer/Principal | 59 | 10-08-23 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Kerry Hicks
BRD | Director/Board Member | 64 | 10-08-23 |
Mats Wahlström
CHM | Chairman | 70 | 10-08-23 |
George Martin
BRD | Director/Board Member | 65 | 10-08-23 |
David Matlin
BRD | Director/Board Member | 62 | 10-08-23 |
Sean Murphy
DFI | Director of Finance/CFO | 71 | 10-08-23 |
Mary Szela
CEO | Chief Executive Officer | 60 | 01-01-18 |
Director/Board Member | 82 | 10-08-23 | |
Arjun Desai
BRD | Director/Board Member | 42 | 10-08-23 |
Anil Singhal
BRD | Director/Board Member | 72 | 10-08-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 27 159 327 | 12 202 622 ( 44,93 %) | 0 | 44,93 % |
Bedrijfsgegevens
Sector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+11,12% | 264 mln. | |
+9,42% | 115 mld. | |
+11,84% | 106 mld. | |
-2,65% | 21,96 mld. | |
-14,15% | 21,87 mld. | |
-5,29% | 19,21 mld. | |
-4,16% | 18,08 mld. | |
-38,29% | 17,71 mld. | |
+7,99% | 14,32 mld. | |
+36,24% | 12,42 mld. |
- Beurs
- Aandelen
- Koers TLSI
- Onderneming TriSalus Life Sciences, Inc.